Philip Charles Hoffman to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Philip Charles Hoffman has written about Antimetabolites, Antineoplastic.
Connection Strength
0.242
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.166
-
Immune hemolytic anemia--selected topics. Hematology Am Soc Hematol Educ Program. 2009; 80-6.
Score: 0.076